Chiltern International Ltd. Wins Two Pharma Awards at the Prestigious Annual Pharmatimes Awards Ceremony

LONDON, Feb. 17, 2012 /PRNewswire/ -- Chiltern International Limited (Chiltern), a global contract research organization (CRO), announced that Chiltern has won two awards at the PharmaTimes Annual Awards 2011 ceremony held February 16, 2012 at the Park Plaza Riverbank Hotel in London. The competition, established in 1999, celebrates the competence and ability of top clinical research professionals.

Glenn Kerkhof, Chiltern CEO, congratulates all of Chiltern’s Award Winners and Finalists. “I couldn’t be more proud of every Chiltern colleague nominated for an award and this recognition is a testament to their outstanding abilities. Their achievements support Chiltern’s mission to deliver high quality services around the world, while demonstrating our commitment to clients’ needs.”

Linda Christmas, Sr. Executive VP, Global Resourcing Solutions, Chiltern, stated, “I am delighted that our finalists represent not only Chiltern’s outstanding operational people but also our dedicated and professional recruitment team. This further demonstrates not only our ability to deliver world class operational services via our internal teams, but also to place exceptional talent direct with our clients and furthermore an outstanding recruitment and personnel placement service. I am absolutely delighted to be able to work with such a great team each and every day.”

Chiltern Award Winners

Clinical Recruiter of the Year Bronze Award: Marc Joseph, Resourcing Manager, Chiltern Resourcing Solutions

Clinical Research Associate of the Year Silver Award: Danielle Fairclough, client based Clinical Research Professional via Chiltern Resourcing Solutions

Company profile

About Chiltern:

Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs nearly 1,300 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at: www.chiltern.com.

SOURCE Chiltern